Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-09

Clinical Trial Update: Observational Study of Meloxicam in Mexican Patients With Rheumatic Diseases

View source ↗

Summary

A completed observational study evaluated the use of meloxicam in Mexican patients with rheumatoid arthritis and other rheumatic diseases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MELOXICAM (MELOXICAM)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Status: COMPLETED